Showing results (391-400 of 461) with videos related to
Sort By:
Pageof 47
Journal of Cancer Research and Clinical Oncology|October 3, 2014
ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapyTakamasa Takahashi, Satoshi Yamahsita, Yasunori Matsuda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 16, 2013
[A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy]Akihiro Hirata, Keita Itatsu, Masahide Fukaya, et al.ANZ Journal of Surgery|December 22, 2017
Application of three-dimensional print in minor hepatectomy following liver partition between anterior and posterior sectorsTsuyoshi Igami, Yoshihiko Nakamura, Masahiro Oda, et al.Surgical Case Reports|December 4, 2017
Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivorKentaro Shinohara, Tomoki Ebata, Yukihiro Yokoyama, et al.Biochemical and Biophysical Research Communications|July 17, 2007
SIRPalpha1 and SIRPalpha2: their role as tumor suppressors in breast carcinoma cellsYukiko Yamasaki, Satoko Ito, Nobuyuki Tsunoda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2012
[Borderline resectable pancreatic cancer - a definition and effective treatment strategy]Yukihiro Yokoyama, Tomoki Ebata, Tsuyoshi Igami, et al.Clinical Nutrition (Edinburgh, Scotland)|November 14, 2021
Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: A randomised controlled trialMasahide Fukaya, Yukihiro Yokoyama, Hiroaki Usui, et al.Journal of Hepato-Biliary-Pancreatic Sciences|September 15, 2019
Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 casesRohan Jagat Chaudhary, Ryota Higuchi, Masato Nagino, et al.Annals of Surgery|March 8, 2022
Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)Junpei Yamaguchi, Yukihiro Yokoyama, Tsutomu Fujii, et al.Surgery Today|January 29, 2020
Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancerToshiki Mukai, Keisuke Uehara, Toshisada Aiba, et al.Pageof 47